AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $124,000 | +103.3% | 8,192 | 0.0% | 0.00% | – |
| Q2 2022 | $61,000 | -18.7% | 8,192 | 0.0% | 0.00% | – |
| Q1 2022 | $75,000 | +29.3% | 8,192 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | -37.6% | 8,192 | 0.0% | 0.00% | – |
| Q3 2021 | $93,000 | -29.0% | 8,192 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $131,000 | -10.3% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $146,000 | +31.5% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $111,000 | +15.6% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $96,000 | -20.7% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $121,000 | +9.0% | 8,192 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $111,000 | +4.7% | 8,192 | +87.5% | 0.00% | 0.0% |
| Q4 2019 | $106,000 | +26.2% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $84,000 | -34.9% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $129,000 | -38.0% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $208,000 | +31.6% | 4,370 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $158,000 | -41.3% | 4,370 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $269,000 | +35.2% | 4,370 | +48.6% | 0.00% | +100.0% |
| Q2 2018 | $199,000 | +25.2% | 2,940 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $159,000 | -9.7% | 2,940 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $176,000 | – | 2,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |